Corrigendum to “Biodegradable thermal imaging-tracked ultralong nanowire-reinforced conductive nanocomposites elastomers with intrinsical efficient antibacterial and anticancer activity for enhanced biomedical application potential” [Biomaterials 201 (2019) 68–76] (Biomaterials (2019) 201 (68–76), (S0142961219300985), (10.1016/j.biomaterials.2019.02.013))

The authors regret that fluorescent image in Fig. 5a on PCS-CSNW0% and the HE images in Fig. 5e (NC at 4W, PCS-CSNW 0% at 2W/4W) was reproduced incorrectly. In this work, to confirm the reliability, we performed these HE staining experiments for two times and the mistaken images (the first time) were incorrectly reproduced instead of the correct images (the second time). We confirm that these mistakes have no effect on the conclusion in this paper (no significant difference between mistaken and correct image). The correction does not change the text content and the conclusion of this work. The authors would like to apologise for any inconvenience caused. [Figure presented] Fig. 5. Biocompatibility evaluation in vitro/in vivo and in vitro photothermal cancer cell therapy of multifunctional PCS-CSNW nanocomposites. a) Live-Dead staining of L929 cells after culture for 1 day (Scale bar = 200 μm); b) Cells proliferation of PCS-CSNW nanocomposites, b-1) L929 Cells proliferation after incubation for 1, 4, and 5 d on the surface of nanocomposites films, b-2) L929 cells proliferation after incubation with extract solution at different concentrations of nanocomposites for 1 and 3 d, b-3) HepG2 cancer cells proliferation after incubation with various nanocomposites before and after 980 nm laser irradiation; c) In vivo inflammatory response evaluation of PCS-CSNW nanocomposites, c-1) Representative H&E staining sections pictures after 2 and 4 weeks implantation in vivo (scale bar: 100 μm), c-2) Infiltrated cells and c-3) average fibrous capsule thickness statistics based on the H&E stained histological sections of the subcutaneous tissue surrounding PCS-CSNW 0% and PCS-CSNW 2.5% nanocomposites after 2 and 4 weeks in vivo. Blank H&E section was used as the negative control (NC). (*p < 0.05 and **p < 0.01.)